Home

Articles

Pearls of Wisdom for Getting the Most out of the 2011 BIO International Convention

Recently the Oklahoma Bioscience Association held a 2011 BIO International Convention information session for their delegates to get ready for the June event.

2011 Biotech Humanitarian Award Nominations Close on April 15

Last year, stem cell advocate Robert Klein was named the 2010 Biotech Humanitarian Honoree. Who will be named this year's Honoree?

The Cost of Losing Innovation

Current rules resulting from a 2003 Office of Hearings and Appeals decision have inhibited and interfered with the growth and survival of small private biotechnology companies and the development of promising technologies and products

Moving Forward: USDA Awards Additional Loan Guarantees for Refineries

The Agriculture Department has announced additional money for loan guarantees to support construction of new advanced biofuel biorefineries.

Brent Ahrens, general partner with Canaan Partners and organizer of a 2011 BIO International Convention session focused on venture capital funding for biotech companies

On a Roll: Governor Seeks Continued Investment in BioMaryland 2020

The Maryland initiative’s 10-year plan helps build biotech access to funding

Top Ten "Must Attend" Breakout Sessions at the 2011 BIO International Convention

GEN's Editor-in-Chief John Sterling outlines his picks for the top ten "must attend" breakout sessions at the 2011 BIO International Convention.

World Health Day: The Global Impact of Vaccines

As we celebrate World Health Day today, it is an opportunity to remember that vaccines represent one of the most important global health investments.

Countdown to Partnering - John Carroll, Editor of Fierce Biotech

 John Carroll, editor of Fierce Biotech, shares what he won't miss at the 2011 BIO International Convention.

Japan’s Crippled Nuclear Plant Demonstrates Need for New Radiation Treatments

As Japan works to stabilize the crippled nuclear power plant in Fukushima, people are stocking up on potassium iodide tablets – one of the only drugs available to block the body's absorption of some radioactive materials.

FDA Funding: Budget Increase Sought for 2012

President’s call for more funding comes as Congress focuses on reducing budget deficits.

BIO Business Forum Partnering: Building Value through Partnerships

Partnering decisions can make or break a company’s value. Pursuing the right partnership deal can ultimately increase a company’s value but conversely, the wrong decision can ultimately kill a company’ value.

A Meating of Minds: Five Nations Voice Support for Livestock Cloning

Fifteen years after Dolly, the first mammal to be cloned from an adult cell rather than an embryo, made headlines, the process of livestock cloning is increasingly gaining acceptance as a viable means of satisfying demand for sustainable food production.

Biotech Solutions for Renewable Specialty Chemicals & Food Ingredients

Introduction

Many of the products consumers purchase and use on a daily basis are made from petroleum, natural gas or petrochemicals. The availability and affordability of these products contributes to improved standards of living in countries around the world.

Derek Gregg, Chair of BioWV and Chief Executive Officer of Vandalia Research

BIOtechNow’s Tracy Cooley discusses biotech in West Virginia – major growth areas, outlook for the future, and upcoming plans for the BIO International Convention – with Derek Gregg.

IP: Imperative for Innovation

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

Bright Prospects: Biotech Execs Predict Continued Growth in 2011

Upward trends and investment opportunities will be focus of BIO’s World Congress in May.

FAQs About Biotech Crops and Labeling

Agricultural biotechnology can be a key element in the fight against hunger and malnutrition in the developing world.

Massachusetts Life Sciences Center Awards $3.75 Million to Early Stage Companies

The Massachusetts Life Sciences Center, which is tasked with administering the $1 billion state's life sciences initiative, has awarded five loans to start up companies, totaling $3.75 million.

Market Watch: Revamped Website Offers Agri-Biotech Product Info

Overhauled BIOTradeStatus lets users search for the latest information on hundreds of products.

Continuing the Legacy: BIO to Present George Washington Carver Award

Honoring the father of chemurgy, the award will be presented at the World Congress on Industrial Biotechnology and Bioprocessing in May.

Virginia Makes Gains: Lawmakers Pass Biotech-Friendly Budget

Budget victories will help biotechnology in the Commonwealth

Senate committee marks up SBIR/STTR reauthorization

On March 9, the U.S. Senate Small Business and Entrepreneurship Committee voted 18-1 to pass the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Reauthorization Act of 2011 (S. 493). The bill includes provisions that would allow 25 percent of these grants to go to companies that are primarily backed by venture capital. The bill now goes to the full Senate. 

New Heights: Report Shows Continued Growth of Biotech Crops

ISAAA data shows countries around the world have embraced agricultural biotechnology.

Innovation Wanted

Bringing biotechs into global health R&D.